We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$4.11B
1-Year Est. Return
26.03%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+26.03%
3 Year Est. Return
+55.81%
5 Year Est. Return
+76.4%
10 Year Est. Return
+190.66%
AUM
$8.22B
AUM Growth
+$272M
(+3.4%)
Cap. Flow
-$1.22B
Cap. Flow
% of AUM
-14.9%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.09% |
| 2 | Consumer Staples | 9.92% |
| 3 | Healthcare | 9.5% |
| 4 | Technology | 7.01% |
| 5 | Consumer Discretionary | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Verizon
VZ
$214B
| $51.7M | 0.63% |
1,055,895
-115,122
| -10% | -$5.58M |
|
27
Baxter International
BAX
$12.3B
| $51.5M | 0.63% |
1,310,212
-68,001
| -5% | -$2.72M |
|
|
28
ExxonMobil
XOM
$696B
| $51.5M | 0.63% |
511,024
+485,463
| +1,899% | +$49M |
|
29
McKesson
MCK
$104B
| $51.2M | 0.62% |
274,782
+210,866
| +330% | +$37.5M |
|
30
Home Depot
HD
$306B
| $49.9M | 0.61% |
616,212
-82,825
| -12% | -$6.53M |
|
31
Zimmer Biomet
ZBH
$18.6B
| $49.1M | 0.6% |
486,849
+412,464
| +554% | +$40.2M |
|
32
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$799B
| $48.9M | 0.6% |
+250,000
| New | +$47.5M |
|
|
33
Colgate-Palmolive
CL
$69.3B
| $48.8M | 0.59% |
715,172
+676,943
| +1,771% | +$45.4M |
|
34
Hershey
HSY
$34.3B
| $44.8M | 0.55% |
460,321
+274,744
| +148% | +$26.9M |
|
|
35
CF Industries
CF
$20.3B
| $43.7M | 0.53% |
908,925
+864,845
| +1,962% | +$42.3M |
|
36
Coca-Cola
KO
$380B
| $43.7M | 0.53% |
1,031,116
-141,584
| -12% | -$5.74M |
|
|
AGN
37
CALL
DELISTED
Allergan Inc
AGN
| $42.3M | 0.51% |
+250,000
| New | +$38.9M |
|
38
Philip Morris
PM
$303B
| $42.1M | 0.51% |
498,766
-162,280
| -25% | -$14M |
|
39
Public Service Enterprise Group
PEG
$35B
| $41.8M | 0.51% |
1,025,604
+994,236
| +3,170% | +$38.6M |
|
40
Zoetis
ZTS
$30.4B
| $41.5M | 0.5% |
1,285,091
-483,498
| -27% | -$14.8M |
|
41
Intuit
INTU
$89.1B
| $41.2M | 0.5% |
511,074
+260,565
| +104% | +$20.1M |
|
42
Bausch Health
BHC
$2.13B
| $38.6M | 0.47% |
+305,899
| New | +$39M |
|
43
Kinder Morgan
KMI
$68.4B
| $38M | 0.46% |
1,046,943
-788,836
| -43% | -$26.6M |
|
44
Welltower
WELL
$167B
| $37.5M | 0.46% |
599,082
+530,000
| +767% | +$33.4M |
|
45
SBA Communications
SBAC
$19.3B
| $35.4M | 0.43% |
346,162
+145,980
| +73% | +$14M |
|
46
IBM
IBM
$236B
| $33.2M | 0.4% |
+191,743
| New | +$34.5M |
|
|
TWC
47
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $33.1M | 0.4% |
225,000
+144,408
| +179% | +$20.3M |
|
48
Altria Group
MO
$117B
| $32.3M | 0.39% |
770,162
+454,623
| +144% | +$18.3M |
|
49
Progressive
PGR
$128B
| $31.8M | 0.39% |
+1,254,972
| New | +$31.1M |
|
50
PVH
PVH
$3.35B
| $31.8M | 0.39% |
+272,369
| New | +$33.9M |
|
Similar funds
DS
GCC
BHC
BB
DWP
PL
JIM
FMII
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $1.22B in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, down from 46% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.